$269,952,453

Department of Health and Human Services·Office of Assistant Secretary for Preparedness and Response

ACTION DATE—·SOURCEUSASPENDING·SOURCE IDCONT_AWD_75A50121C00020_7505_-NONE-_-NONE-

Award description

OTHER TRANSACTION AGREEMENT: BARDA VENTURES

Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.

The Buildout's read

What the model surfaced from this award

Confidence: high

In plain English

BARDA Ventures invests in biotech companies developing medical countermeasures and pandemic preparedness solutions.

Sub-sectors

pandemic-preparednessmedical-countermeasuresventure-capital

Why this matters

Strengthens U.S. capacity to rapidly develop and deploy medical countermeasures against biological threats and emerging infectious diseases.

Supply-chain signal

Signals investment in diversifying biotech manufacturing and supply chains for critical medical products and vaccines.

U.S.–China competition angle

Reduces U.S. dependence on foreign biotech capabilities and strengthens domestic innovation in pandemic response technologies.

Generated by award_classification v1.0.0 via claude-haiku-4-5-20251001 on 2026-05-13. Cost: $0.001330.

Period of performance

Start

2021-06-01

End

2031-06-01

Status

activein 1843 days

Recipient

Sources

USAspending.gov — all awards for this UEI →
SAM.gov entity registration →
Award record ingested from usaspending. Source identifier CONT_AWD_75A50121C00020_7505_-NONE-_-NONE-.

The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.